| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,030 | 2,685 | 3,732 | 2,988 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 4,030 | 2,685 | 3,732 | 2,988 | | | Operating Expenses | | Research Development | 7,241 | 7,802 | 8,686 | (18,743) | | Selling General and Administrative | 3,850 | 3,510 | 3,341 | 29,269 | | Non Recurring | 604 | 0 | (604) |
-
| | Others | 95 | 96 | 95 | 104 | | | | Total Operating Expenses | 11,790 | 11,408 | 11,518 |
-
| | | | Operating Income or Loss | (7,156) | (8,723) | (7,786) | (7,641) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 586 | 19 | 82 | 188 | | Earnings Before Interest And Taxes | (6,570) | (8,704) | (7,704) | (7,453) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (6,570) | (8,704) | (7,704) | (7,453) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,570) | (8,704) | (7,704) | (7,453) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,174) | (8,704) | (7,704) | (7,453) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,174) | ($8,704) | ($7,704) | ($7,453) |
|
0.83% Nasdaq 
0.01 (0.23%) 
Income Statement
